With nearly one-third of all UW startups emerging from EE in 2013, it seems fitting that the academic year will end with a graduation speaker who has been a leader in supporting UW startups. Tom Clement, a serial entrepreneur and former director of New Ventures – Life Sciences for C4C, has been selected as the department’s 2014 graduation speaker.
Clement has over 30 years of experience in product development engineering, engineering management, and senior management. He is currently the CEO of Aqueduct Neurosciences, Inc., a start up company that develops products to treat hydrocephalus, a condition where the cerebral spinal fluid is not re-absorbed by the human brain. He was also the CEO of Cardiac Insight, Inc., a start up company, which addressed the “silent” a-fib market by developing a highly accurate atrial fibrillation monitor for patients with undiagnosed, difficult to detect atrial fibrillation.
In 2009, Clement joined UW C4C, and became the Director of New Ventures – Life Sciences to help identify technologies that have the potential for commercialization via a new start up. In his role, he worked with researchers and UW personnel to advance the business plans for the identified commercial prospects in areas spanning market strategy, regulatory strategy, identification of management teams, and early stage financing.
In 1998, Clement co-founded Pathway Medical Technologies, Inc. and served as CEO until September 2008. He led a talented management team, which developed and brought to market its flagship product, the JetstreamtmSystem for treatment of peripheral arteries. Clement previously was a founding employee and held senior management roles at Heart Technology, which grew to more than $100 million in revenue and 550 employees. When Heart Technology was acquired by Boston Scientific, Clement became responsible for the emerging cardiovascular technologies group of the Scimed Division.
Clement earned his BSEE in 1979 and his MSEE in 1981, both from the UW. He sits on the boards of several start up companies. He is the immediate past Chairman of the Board of Directors for the Washington Biotechnology and Biomedical Association (WBBA), and is a founder and the current co-Chairman of the Board of Directors for the Medical Technology Angel Network, WINGS. Clement was also appointed by Governor Gregoire to the Washington Global Health Technologies Competitiveness Board. He is also on the Visiting Committee for the UW’s Educational Outreach Programs.